A Case Study of Malignant Germ Cell Tumor Patient Experiencing Chemotherapy Side Effects Managed by Traditional Korean Medicine
![]() |
Jeong, So-Mi
(Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University) Lee, Jin-Moo (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University) Lee, Chang-Hoon (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University) Jang, Jun-Bock (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University) |
1 | Han GJ, et al. A case study of a patient with breast cancer treated with a combination of traditional Korean medicine and chemotherapy. J Int Korean Med. 2017;38(5):820-7. DOI |
2 | Kwon SJ, et al. EuiMunChuiEeon (醫門贅言) Wonju:Publishing Co. Eui bang 2014:124-6. |
3 | Lee JD. The Physio-pathology of Oriental Medicine with 30 Essential Herbal Formulas. Seoul:Publishing Co. Jeong-dam. 2015:414-40. |
4 | Song MS, et al. The Study of Literature Review on Lacas Sinicia Exsiccate. The Journal of Korean Obstetrics and Gynecology. 2002;15(1):61-76. |
5 | Kwon SW, et al. Korean Internal Medicine Diagnosis&Treatment (韓方內科診察診斷治療) Goyang:Guide. Gaonhamedia. 2017:84-8. |
6 | Ohno T, et al. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin -induced anorexia in humans. Clin Exp Gastroenterol. 2011;4(1):291-6. DOI |
7 | Lin JC, et al. Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival. J Clin Oncol. 2003;21(4):631-7. DOI |
8 | Huddart RA, et al. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). Eur Urol. 2015;67(3):534-43. DOI |
9 | Tryakin A, et al. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with non-seminomatous germ cell tumors: a phase II study. Urology. 2011;78(3):620-5. DOI |
10 | Kier MG, et al. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study. Eur Urol. 2017;71(2):290-8. DOI |
11 | David M, et al. Managemnt of Early Ovarian Cancer: Germ cell and Sex Cord-Stromal Tumors. Gynecol Oncol. 1994;55(3):562-72. DOI |
12 | Chang HJ, et al. A case of Ovarian Mixed Germ cell tumor with rapid relapse. Journal of Gynecologic Oncology. 2002;13(2):171. |
13 | Kim CS, et al. A Literature Review of the East-West Medical Combined Treatment) Korean Institute of Oriental Medicine. 2012;18(2):101-16. |
14 | Dundee JW, et al. Acupuncture prophylaxis of cancer chemotherapy-induced sickness. J R Soc Med. 1989;82(5):268-71. DOI |
15 | The Society of Korean Medicine Obstetrics and Gynecology. Oriental Obstetrics & Gynecology. Seoul:Publishing Co. Eui Seong Dang. 2012:347-52. |
16 | Ministry of Health and Welfare, National Cancer Control Institute. Cancer registration.Statistics Program. 2016. |
17 | Jacobs IJ, et al. Screening for ovarian cancer: a pilot randomized controlled trial. Lancet. 1999 Apr 10;353(9160):1207-10. DOI |
18 | Nogales FF, et al. Germ cell tumors of the ovary: an update. Arch Pathol Lab Med. 2014;138(3):351-62. DOI |
19 | Nawa A, et al. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol. 2001;184(6):1182-8. DOI |
20 | Williams SD, et al. Adjuvant therapy of ovarian germ cell tumors with cisplaitn, etoposide, and bleomycin : a trial of the Gynecologic Oncology Group. Gynecol Oncol. 2004;95(3):496-9. DOI |
21 | Zanetta G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19(4):1015-20. DOI |
22 | Lee KW, et al. A Preliminary Study for Development of Clinical Practice Guidelines of Korean Medicine in Breast Cancer. The Journal of Korean Obstetrics and Gynecology. 2016;29(2):47-66. DOI |
23 | Mead GM, et al. The International Germ Cell Consensus Classification : a new prognostic factor-based staging classification for metastatic germ cell tumors. Clin Oncol. 1997;9(4):207-9. DOI |
24 | Kim CM, et al. The encyclopedia of oriental herbal medicine. Publishing Co. Jungdam. 1997;(7):3473-9. |
25 | Wang JH, et al. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumour Biol. 2014;35(12):11985-94. DOI |
26 | Xu TM, et al. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin Med J (Engl). 2008;121(15):1394-7. DOI |
27 | National Compilation Committee of Korean Medicine college(全國韓醫科大學共同敎材編纂委員會). Herbalogy (本草學) Seoul:Publishing Co. Young rim. 2016:320-4. |
28 |
Ting Liu, et al. Ginsenoside 20(S)-Rg3 Targets HIF- |
29 | Li J, et al. Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells. Int J Oncol. 2015;46(2):775-81. DOI |
30 | Zheng X, et al. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Biomed Pharmacother. 2017;85:620-6. DOI |
31 | Kang H, et al. Astragali Radix Increases Survival and Activity of Spleen Lymphocyte. Journal of physiology & pathology in Korean medicine. 2001;15(4):560-5. |
32 | Cho WC, et al. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett. 2007;252(1):43-54. DOI |
33 | Evan GI, et al. Proliferation, cell cycle and apoptosis in cancer. Nature. 2011;411(6835):342-8. DOI |
34 | Park JG, et al. Effects of Astragalus membranaceus Extract on Cell Cycle and Apoptosis of Human Leiomyoma Cell. The Journal of Korean Obstetrics and Gynecology. 2008;21(2):49-58. |
35 | Nancy A. The caspase family of cysteine proteases. British Medical Bulletin. 1997;53(3):478-90. DOI |
36 | Lee DH, et al. A case report of metastatic breast cancer treated with korean medicine therapy as a substitute for chemotherapy. Case Rep Oncol. 2017;10(1):27-36. DOI |
37 | Han GJ, et al. A case study of an advanced breast cancer patient treated with a combination of traditional korean medicine and chemotherapy. J Int Korean Med. 2018;39(2):268-76. DOI |
38 | Shin MG. Clinical Traditional Herbalogy. Seoul:Publishing Co. Young-rim. 1989:55-7 |
39 | David D.Kitts, et al. Antitumorigenic and cytotoxic properties of an ethanol extract dervied from Rhus Verniciflua Stokes. J Toxical Environ Health A. 2001;64(4):357-71. DOI |
40 | Oh PS, et al. Glycoprotein Isolated from Rhus verniciflua stokes Inhibits Inflammation-Related Protein and Nitric Oxide Production in LPS-Stimulated RAW 264.7 Cells. Biol Pharm Bull. 2007;30(1):111-6. DOI |
41 | Lee JH. The effect of G2 cell cycle arrest in ATM/ATR-cdc25c-cdc2-cyclin B pathway by Butein-the active material of Rhus verniciflua stokes in Human breast cancer MCF-7 cell lines. Department of Oriental Medicine, Kyung Hee Graduate School. 2010. |
42 | Jang HJ. Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemo-resistance in MCF-7/DOX cells. Department of Clinical Korean Medicine, Kyung Hee Graduate School. 2017. |
43 | Williams P, et al. Apoptosis: Pharmacological Implications and Therapeutic Opportunities. Mayo Clinic Proceedings. 1998;73(9):917. |
![]() |